2014 Competition Doctors 
Pharmaceutical Technology
OCTOBER 5, 2022
Between 2009 and 2014, the time period of Biogen’s alleged misconduct, the standard of care for MS involved the use of Biogen’s immunomodulatory drugs such as Avonex (Interferon beta-1a), Tecfidera (dimethyl fumarate), and Tysabri (natalizumab). More recently, Biogen has been facing competition from dimethyl fumarate generics.
European Pharmaceutical Review
DECEMBER 21, 2022
16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. Chem Commun 2014, 50, 9650‒9652. Hoffmann-La Roche Ltd based in Basel, Switzerland. Org Process Res Dev 2022, 26, 9, 2685–2693.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Evolve Your Success
FEBRUARY 6, 2024
He also talks about partnering with small businesses and how they are leading the competition in this particular space. I find reps, doctors, and directors. The way these doctors make decisions and the way these things occur, for whatever reason, it fascinated me. I left them in 2014 to start our own thing. They got big.
Cadensee
JULY 26, 2021
Until back in 2014, I met the team at Schneider Children's Medical Center of Israel. They were just at the phase when they were looking for someone to come up with a more business perspective to join the doctors and really start to commercialize the supplements that were just developed at Schneider's at the time.
Clarify Health
MARCH 15, 2023
And frankly, if you’re paying a provider 57% of the 2014 CMS schedule, they’re not going to be terribly excited about you putting this bonus program in front of them when they’re concentrating on that. You are not trying to, as the payer, out-doctor your doctors. They’re competitive by nature.
Evolve Your Success
JANUARY 23, 2024
Sometimes my competition will take that article and say, “I could plus or minus 10 millimeters.” The pathways, honestly, if I were to do it again, the first thing I would do is go find a doctor, any of them depending on what the fields are, and then ask for recommendations for who they work with our current sales reps. It was rough.
Pharmaceutical Technology
JANUARY 6, 2023
The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. These actions allegedly led to the extension of Novartis’ patents. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.
Expert insights. Personalized for you.
59 
Let's personalize your content